ANO1 and glioma: Using a luciferase assay, Liu and colleagues provided evidence for TMEM16A-mediated modulation of glioma proliferation by showing that TMEM16A promotes NF-κB-mediated gene transcription, leading to increased levels of cell cycle regulators cyclin D1, cyclin E, and c-myc [18].